Sonoma Biotherapeutics’ Collaboration Agreement with Regeneron Pharmaceuticals

Pietro Martinoia North America Legal Chronicle
Tagged:

Latham & Watkins advised Sonoma Biotherapeutics on the transaction.Sonoma Biotherapeutics, Inc. and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a collaboration to apply their scientific and clinical…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Pietro Martinoia

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here